Evidence map

ReviewInternational journal of molecular sciences2022

SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection.

Theodoros Androutsakos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

97 papers cite itlatest 60 shown

2022
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35328527